/wion/media/agency_attachments/2024/12/26/2024-12-26t112006978z-wion-white-logo-for-website-2-1.png){kind=logo}
/wion/media/agency_attachments/2024/12/13/2024-12-13t071548098z-wionlogo.webp)
According to a recent Chinese study involving 292 samples, the Sinopharm vaccine jab is weak against the Omicron variant of COVID-19.
Study: Sinopharm vaccine jab weak against Omicron variant of the COVID-19
Advertisment
STORY HIGHLIGHTS
Advertisment